Loading
Life sciences · Journal article
International Journal of Molecular Sciences · October 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Colorectal cancer (CRC) remains a major clinical challenge due to resistance to conventional cell death-inducing therapies. TRAIL selectively induces apoptosis in cancer cells via death receptors, but its effectiveness in preclinical models is limited by tumor resistance mechanisms. Curcumin, a natural polyphenol, modulates multiple survival and apoptotic pathways and has been proposed as a sensitizing agent to overcome TRAIL resistance. Here, we investigated the combinatorial effects of TRAIL and curcumin in the HCT116 colorectal cancer cell model. Cells were treated with TRAIL, curcumin, or their combination for 24 and 48 h, evaluating apoptosis, viability, and underlying mechanisms. Curcumin significantly enhanced TRAIL-induced apoptosis (p < 0.0001) and further reduced MTT-derived metabolic activity (p < 0.01) compared with TRAIL treatment alone. This effect remained evident after 48 h, although the stability and persistence of TRAIL activity were not directly assessed. Mechanistically, combined treatment enhanced PARP cleavage, γ-H2AX phosphorylation, and BAX and Caspase-3 cleavage, while downregulating anti-apoptotic IAP family members. Notably, cotreatment also promoted pyroptosis, shown by characteristic morphological changes (p < 0.0001) and increased Gasdermin-E cleavage. These findings indicate that curcumin sensitizes CRC cells to TRAIL by engaging both apoptotic and pyroptotic pathways, suggesting a potential approach to counteract both TRAIL and multidrug resistance in colorectal cancer.